Providing the AccuSom® Home Sleep Test to people across the United States
Total raised: $35M
Founded date: 2000
Investors 2
| Date | Name | Website |
| - | Emergent M... | emvllp.com |
| - | TPG | tpg.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.06.2011 | - | $35M | - |
Mentions in press and media 7
| Date | Title | Description |
| 06.04.2018 | Term Sheet — Friday April 6 | CRYPTO SOUND-OFF Happy Friday, Term Sheet readers. Paid Content How can you protect what you can't see? From ExtraHop Below, a selection of your responses: Gregg writes: I personally believe ICOs will consume an ever larger piece of the pre... |
| 13.10.2015 | The drug pricing backlash – Should medtech pay attention? | By Amy Siegel, S2N Health Admittedly, the biotech boom of the past few years has left some of us in medtech feeling a bit inferior, maybe even jealous. Those huge funding rounds, heady IPOs and rich pre-revenue M&A deals can be hard to ... |
| 19.04.2013 | At-home testing for sleep apnea draws $32.2M from investors in Florida device company | The chronic condition is characterized by obstruction of the upper airway, which causes pauses in breathing during sleep. When left untreated, it’s been linked to high blood pressure, stroke and heart problems. According to Watermark, its d... |
| 26.10.2012 | 3 companies that reflect Safeguard Scientifics’ healthcare investments | Jim Datin, the executive vice president, explained that it has seen valuations coming down in the healthcare sector “particularly those companies that need a high amount of capital for either commercial launches or getting products approved... |
| 27.06.2011 | NovaSom Closes $35M Equity Financing | NovaSom, Inc., a Burnie, Maryland-based provider of technology-driven, payer-aligned cost-saving solutions for Obstructive Sleep Apnea (OSA) management, has closed a $35m equity financing. The round was led by Safeguard Scientifics, Inc. (N... |
| - | 3 companies that reflect Safeguard Scientifics’ healthcare investments | Safeguard Scientifics’ (NYSE:SFE) third-quarter earnings call this week highlighted areas where the investment firm sees compelling opportunities, particularly in healthcare and life sciences companies. There was also a changing of the guar... |
| - | At-home testing for sleep apnea draws $32.2M from investors in Florida device company | A medical device company hoping to move sleep apnea testing out of expensive and uncomfortable labs and into the realm of primary care has gotten a boost from at least 20 investors. Watermark Medical Inc., which recently merged with sleep d... |